Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02182687 · ClinicalTrials.gov registry record · Phase 2
Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant
A Phase 2 study, sponsored by Lahey Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT02182687 is a Phase 2 study that has completed, run by Lahey Clinic. The registered enrollment target is 60 participants.
The verdict
NCT02182687, a Phase 2 study, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing orthotopic liver transplantation. We propose that SBRT will be associated with longer time intervals between initial treatment and the need for retreatment, compared to TACE, as a "bridge" to orthotopic liver transplantation.
Interventions
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
- PROCEDURE Trans-Arterial Chemoembolization (TACE)
- DRUG Doxorubin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2014-06 |
| Est. Completion | 2021-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02182687
The ClinicalTrials.gov registry entry for NCT02182687 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT02182687 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02182687 about?
NCT02182687 is a clinical study titled "Stereotactic Body Radiation Therapy (SBRT) Versus Trans-Arterial Chemoembolization (TACE) as Bridge to Liver Transplant". This study will compare stereotactic body radiation therapy (SBRT) to trans-arterial chemoembolization (TACE) as a bridging strategy for patients with HCC undergoing orthotopic liver transplantation. We propose that SBRT will be associated with longer time intervals between initial treatment and the...
What is the current status of trial NCT02182687?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2014-06. Estimated completion is 2021-10.
What interventions are being tested in trial NCT02182687?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION), Trans-Arterial Chemoembolization (TACE) (PROCEDURE), Doxorubin (DRUG).
Who is sponsoring clinical trial NCT02182687?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.